Category : Search result: semaglutide injection


Ozempic and Wegovy may increase risk of vision loss

A recent study suggests that popular weight loss drugs Ozempic and Wegovy, containing semaglutide, may increase the risk of a rare eye condition leading to vision loss. Experts urge caution.

Ozempic may cause muscle loss, experts warn

New research warns that popular weight-loss drugs like Ozempic may lead to significant muscle loss, raising concerns among health experts. Discover the risks and alternatives.

Weight returns after stopping skinny jabs

New research warns that patients who stop taking weight-loss injections like Wegovy may regain most of the lost weight, raising concerns about long-term effectiveness.

Weight loss jabs now available in UK pharmacies

Slimming injections, once restricted to clinical settings, are now accessible in UK pharmacies, revolutionising obesity management with easier access and professional oversight.

Weight loss jabs may slash heart attack risk

Breakthrough research suggests that popular weight loss injections like Wegovy and Ozempic may significantly reduce the risk of cardiovascular events, offering hope for millions.

Page 1 of 1